Cargando…

Understanding the Battle for Universal Pharmacare in Canada Comment on "Universal Pharmacare in Canada"

Drug coverage in Canada is a patchwork; an inequitable inefficient and unsustainable patchwork with no coherence or purpose. Some people think that we can solve the problem by adding more patches, but the core of the problem is that it is a patchwork. For the working population, access to medicines...

Descripción completa

Detalles Bibliográficos
Autor principal: Gagnon, Marc-André
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kerman University of Medical Sciences 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7947898/
https://www.ncbi.nlm.nih.gov/pubmed/32610789
http://dx.doi.org/10.34172/ijhpm.2020.40
_version_ 1783663323431043072
author Gagnon, Marc-André
author_facet Gagnon, Marc-André
author_sort Gagnon, Marc-André
collection PubMed
description Drug coverage in Canada is a patchwork; an inequitable inefficient and unsustainable patchwork with no coherence or purpose. Some people think that we can solve the problem by adding more patches, but the core of the problem is that it is a patchwork. For the working population, access to medicines is still organized as privileges offered by employers to their employees. Universal pharmacare would not only provide better access to needed prescription drugs, but also eliminate waste, ensure value-for-money and help improve drug safety and appropriate prescribing. Opponents fear that a universal pharmacare plan would ration drugs, and impede drug access for some patients. However, these claims misunderstand the reality of drug coverage, pricing and access. Opponents propose, instead, to "fill the gap" of current drug coverage by implementing catastrophic coverage, which would serve commercial interests without maximizing health outcomes for the Canadian population. In spite of overwhelming evidence and consensus in the academic community in favour of universal pharmacare, the battle is far from over.
format Online
Article
Text
id pubmed-7947898
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Kerman University of Medical Sciences
record_format MEDLINE/PubMed
spelling pubmed-79478982021-03-16 Understanding the Battle for Universal Pharmacare in Canada Comment on "Universal Pharmacare in Canada" Gagnon, Marc-André Int J Health Policy Manag Commentary Drug coverage in Canada is a patchwork; an inequitable inefficient and unsustainable patchwork with no coherence or purpose. Some people think that we can solve the problem by adding more patches, but the core of the problem is that it is a patchwork. For the working population, access to medicines is still organized as privileges offered by employers to their employees. Universal pharmacare would not only provide better access to needed prescription drugs, but also eliminate waste, ensure value-for-money and help improve drug safety and appropriate prescribing. Opponents fear that a universal pharmacare plan would ration drugs, and impede drug access for some patients. However, these claims misunderstand the reality of drug coverage, pricing and access. Opponents propose, instead, to "fill the gap" of current drug coverage by implementing catastrophic coverage, which would serve commercial interests without maximizing health outcomes for the Canadian population. In spite of overwhelming evidence and consensus in the academic community in favour of universal pharmacare, the battle is far from over. Kerman University of Medical Sciences 2020-03-14 /pmc/articles/PMC7947898/ /pubmed/32610789 http://dx.doi.org/10.34172/ijhpm.2020.40 Text en © 2021 The Author(s); Published by Kerman University of Medical Sciences This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Commentary
Gagnon, Marc-André
Understanding the Battle for Universal Pharmacare in Canada Comment on "Universal Pharmacare in Canada"
title Understanding the Battle for Universal Pharmacare in Canada Comment on "Universal Pharmacare in Canada"
title_full Understanding the Battle for Universal Pharmacare in Canada Comment on "Universal Pharmacare in Canada"
title_fullStr Understanding the Battle for Universal Pharmacare in Canada Comment on "Universal Pharmacare in Canada"
title_full_unstemmed Understanding the Battle for Universal Pharmacare in Canada Comment on "Universal Pharmacare in Canada"
title_short Understanding the Battle for Universal Pharmacare in Canada Comment on "Universal Pharmacare in Canada"
title_sort understanding the battle for universal pharmacare in canada comment on "universal pharmacare in canada"
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7947898/
https://www.ncbi.nlm.nih.gov/pubmed/32610789
http://dx.doi.org/10.34172/ijhpm.2020.40
work_keys_str_mv AT gagnonmarcandre understandingthebattleforuniversalpharmacareincanadacommentonuniversalpharmacareincanada